Clinical Status
Robust Clinical Pipeline
*ALL = Acute Lymphoblastic Leukemia; NHL = Non-Hodgkin’s Lymphoma; CLL = Chronic Lymphocytic Leukemia; AML = Acute Myeloid Leukemia; mRCC = Metastatic Renal Cell Carcinoma; MSK = Memorial Sloan Kettering Cancer Center; IST = Investigator sponsored trial; CST = Corporate sponsored trial
